Paired-like homeodomain transcription factor 2 (PITX2) is a homeobox protein acting as a transcription factor essential for embryonic development, especially in the formation of the eye, teeth, heart, and abdominal organs. It controls left-right asymmetry, regulates gene expression crucial for cell differentiation, and maintains hormone transcription in the anterior pituitary. Mutations or altered PITX2 expression are implicated in congenital developmental disorders, multiple cancers, cardiac arrhythmias, and chemotherapeutic resistance. PITX2 also serves as a disease biomarker and a functional mediator in key developmental and disease pathways.
Other names
Pituitary homeobox 2ARP1RGSRIEGRIEG1IGDSRSBrx1Otlx2ASGD4IDG2IGDS2IHG2IRID2PTX2solurshinhomeobox protein PITX2ALL1-responsive protein ARP1all1-responsive gene 1paired-like homeodomain transcription factor 2rieg bicoid-related homeobox transcription factorring dermoid of cornea syndrome geneanterior segment dysgenesis 4
02
Mechanism of action
Anticancer drugs can have increased or decreased effectiveness depending on PITX2 expression (via regulation of ABCB1 and cancer proliferation-related genes); gene therapy or molecular modulation targeting PITX2 activity or regulatory axis.
03
Biological functions
Embryonic development (eye, tooth, heart, abdominal organs)Left-right asymmetry determinationTerminal differentiation of somatotroph and lactotroph cellsTranscriptional regulation of hormone activity (prolactin) and gene expression (procollagen lysyl hydroxylase)Cell differentiation
Therapeutic challenges include dose-dependent developmental effects, risk of congenital malformations with loss of PITX2 function, and cancer progression with overexpression. Aberrant PITX2 activity can lead to unchecked cell proliferation, resistance to chemotherapeutics, and disrupted cardiac conduction.
06
Interacting drugs
Doxorubicin (drug sensitivity/resistance via downstream gene regulation such as ABCB1 in renal cancer)
07
Biomarkers
PITX2 expression levels may serve as a prognostic marker in several cancers (prostate, breast, lung adenocarcinoma, esophageal squamous cell carcinoma), arrhythmia risk (atrial fibrillation), and cancer therapy response prediction
Beyond the preview
Go deeper on Paired-like homeodomain transcription factor 2 (PITX2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Paired-like homeodomain transcription factor 2 (PITX2).